Zerusa, Vascular Solutions team up for US Guardian distribution:
This article was originally published in Clinica
Executive Summary
Irish medical device company Zerusa and Minneapolis, Minnesota-based interventional cardiology firm Vascular Solutions have entered into a distribution agreement that will see the former's Guardian haemostasis valve distributed in the US by Vascular. The deal could lead to several future distribution partnerships between the two firms, according to the company's CEO Howard Root. The valve is designed to maintain haemostasis during interventional catheterisation procedures, via a sealing system that allows the introduction and removal of interventional devices. It is already on sale in Europe through Zerusa's distribution network and received FDA clearance, in late 2005.